Menu
Shannon Zollo, Nutter McClennen & Fish LLP Photo

Shannon S. Zollo

Chair, Mergers and Acquisitions and Private Equity / Boston

Overview

Shannon S. Zollo is a partner in Nutter’s Corporate and Transactions Department and chair of the firm’s M&A/PE practice group. He advises investor and executive management clients on a wide range of corporate law matters, including mergers and acquisitions, private equity, venture capital, executive compensation, and corporate governance. Clients also frequently rely on Shannon to serve as their outside general counsel.

Notable Experience and Client Impact

  • Represented Ce3, Inc., a full-service CRO focused on providing early phase oncology clinical development services to the biotechnology industry, in connection with its acquisition by Catalyst Clinical Research, a clinical development organization providing highly customizable clinical research solutions to the global biopharmaceutical industry.
  • Represented Copley Equity Partners, a Boston-based private investment firm, in its investment to recapitalize, and facilitate the merger of, Aethon Aerial Solutions and Flight Evolved.
  • Represented Veristat, LLC, a scientifically minded global clinical research organization (CRO), in its acquisition by WindRose Health Investors, LLC, a New York City-based health care private equity firm.
  • Represented Copley Equity Partners in connection with Gregory FCA’s acquisition of Affect, a B2B-focused firm serving technology, health care, and professional services clients.
  • Represented Strategic Cyber LLC, a developer of software for penetration testers and red teams, in connection with its acquisition by HelpSystems, a Minnesota-based IT software company.
  • Represented Copley Equity Partners in its minority growth capital investment in Gregory FCA, one of the nation's 50 largest public relations firms.
  • Represented Innovation Associates, the market-leading provider of high-volume pharmacy automation technology and software solutions to the retail, hospital, government, and mail order pharmacy markets, in connection with a consortium of investors led by Greg Wasson, the former Walgreens Boots Alliance CEO, acquiring a majority stake to scale the business and enhance its pharmacy automation offerings. 
  • Represented McCarthy Capital Fund VI in connection with its partnership with Big Belly Solar, the global leader in smart waste solutions for public spaces, to recapitalize Bigbelly and provide further cash investment to accelerate growth. 
  • Represented Globe Composite Solutions, LLC, a navy submarine supplier, in its acquisition by ESCO Technologies Inc. (NYSE: ESE), a global provider of highly engineered products and solutions to diverse and growing end-markets.
  • Represented DTM Packaging and Custom Automation, a leader in machinery manufacturing and re-manufacturing, in its acquisition by The Massman Companies, a Minnesota-based team of machinery and technology companies.
  • Represented Firehouse Capital, Inc., a privately held investment company with a focus on investments in early stage technology companies and real estate, in its investment of the acquisition of TLC@Home, a leading non-medical home care agency.
  • Advised Invoke Solutions, Inc., a market research company with a unique platform for large scale focus groups, in a merger transaction with Academic Management Systems, Inc., which provides academic productivity software.
  • Represented Audley Travel US, Inc., a subsidiary of a leading private equity backed UK travel service, in its negotiation of a major credit facility with Barclays Bank.
  • Advised Epoxy Technologies, Inc., a leading manufacturer of specialty adhesives, in its acquisition of JP Kummar GmbH.
  • Represent Bone Biologics (OTC: BBLG), a developer of orthobiologic products, in corporate governance and securities law matters.
  • Represent BioAxone BioSciences Inc., a clinical-stage biotechnology company dedicated to developing new medicines to treat patients with SCI, neurotrauma and neurovascular disorders, in corporate governance and licensing matters.
  • Represented Blue Stream Laboratories, Inc., an analytical contract research organization (CRO) supporting the development of complex biologics and biosimilars, in its acquisition by Charles River Laboratories International, Inc. (NYSE: CRL).

  • Represented Virgin Pulse, the leading habits-focused well-being company, in a growth equity/recapitalization financing led by Insight Venture Partners.

  • Advised Danlin Industries, Inc., a specialty chemical supplier to the oil and gas industry, in its sale to Arsenal Capital Partners.

  • Represented ETEX Holdings, Inc., a provider of nanocrystalline calcium-phosphate-based biomaterials that promote the repair and regeneration of damaged bone, in its acquisition by Zimmer Biomet.

  • Represented 3C Electrical Company, Inc., a recognized leader in the electrical power industry, in in its acquisition by CE Power Solutions, LLC, a private equity backed, leading-edge provider of asset integrity for new and existing electrical power systems.

  • Represented Tivoli Audio LLC, an iconic high-performance audio company, in its acquisition by Toronto-based Serruya Private Equity to serve as its flagship consumer electronics brand.

  • Represented Fluid Management Holdings, LLC, a provider of water hauling, disposal, and acid services for oil and gas exploration and production companies, in its sale to Prospect Capital Corporation.

  • Represented Sabal Medical, Inc., a privately held company whose products are helping hospitals deliver medications to their patients more safely and efficiently, in its sale to Swisslog USA, Inc.

  • Represented MacSpeech, Inc., a provider of speech recognition software, in its sale to Nuance Communications.

  • Represented Webb Research Corporation, a designer and manufacturer of scientific instruments for oceanographic research and monitoring, in its sale to Teledyne Technologies.

  • Represented Seacon Phoenix Incorporated, a provider of undersea electrical interconnect subsystems to the global submarine market, in its sale to Ametek, Inc.

  • Represented Genzyme Corporation, a biotech company focused on discovering and delivering medicines for rare diseases & MS, in a sale of certain assets to Cell Genesis, Inc.

Active in numerous professional and civic organizations, Shannon is the co-founder of Exit Planning Exchange (XPX), a multi-disciplinary community of professional advisors who help owners build and transition the value of their businesses, and a member of the board of directors of the TB12 Foundation, LLC, a non-profit organization that is dedicated to maximizing the health, well-being, and athletic potential of elite young American amateur athletes. In addition, he is a member of ACG Boston (Association for Corporate Growth) and a member of the board of trustees of Cristo Rey Boston High School, where he chairs the Development Committee.

Shannon often presents and is quoted in the media on business issues, including transactions, financing, and emerging trends in private equity and venture capital. He is fluent in Portuguese.

Prior to joining Nutter, Shannon was a partner at a prominent Massachusetts law firm. Previously, he served as general counsel at a telecommunications company.

Experience

Experience

  • Ce3, Inc.

    Nutter served as legal counsel to Ce3, Inc., a full-service CRO focused on providing early phase oncology clinical development services to the biotechnology industry, in connection with its acquisition by Catalyst Clinical Research, a clinical development organization providing highly customizable clinical research solutions to the global biopharmaceutical industry.

  • Strategic Cyber LLC

    Nutter advised Strategic Cyber LLC in connection with its acquisition by HelpSystems, a Minnesota-based IT software company.

  • Copley Equity Partners

    Nutter served as legal counsel to Copley Equity Partners, a Boston-based private investment firm, in its minority growth capital investment in Gregory FCA, one of the nation’s 50 largest public relations firms.

  • Innovation Associates

    Nutter served as legal counsel to Innovation Associates, the market-leading provider of high-volume pharmacy automation technology and software solutions to the retail, hospital, government, and mail order pharmacy markets, in connection with a consortium of investors led by Greg Wasson, the former Walgreens Boots Alliance CEO, acquiring a majority stake to scale the business and enhance its pharmacy automation offerings.

  • McCarthy Capital

    Nutter served as legal counsel to McCarthy Capital Fund VI in connection with its partnership with Big Belly Solar, the global leader in smart waste solutions for public spaces, to recapitalize Bigbelly and provide further cash investment to accelerate growth.

  • DTM Packaging and Custom Automation

    Nutter served as legal advisor to DTM Packaging and Custom Automation, a leader in machinery manufacturing and re-manufacturing, in its acquisition by The Massman Companies, a Minnesota-based team of machinery and technology companies.

  • Globe Composite Solutions, LLC

    Nutter served as legal advisor to Globe Composite Solutions, LLC (Globe), a navy submarine supplier, in its acquisition by ESCO Technologies Inc. (NYSE: ESE), a global provider of highly engineered products and solutions to diverse and growing end-markets that include the aerospace, space, healthcare, wireless, consumer electronics, electric utility, and renewable energy industries. 

  • Copley Equity Partners

    Nutter served as legal counsel to Copley Equity Partners, a Boston-based private investment firm, in connection with Gregory FCA’s acquisition of Affect, a B2B-focused firm serving technology, health care, and professional services clients. Gregory FCA, one of the nation’s 50 largest public relations firms, is a Copley portfolio company.

  • Copley Equity Partners

    Nutter served as legal counsel to Copley Equity Partners, a Boston-based private investment firm, in its investment to recapitalize, and facilitate the merger of, Aethon Aerial Solutions and Flight Evolved.

  • Veristat, LLC

    Nutter served as legal counsel to Veristat, LLC, a scientifically minded global clinical research organization (CRO), in its acquisition by WindRose Health Investors, LLC, a New York City-based health care private equity firm.

News & Insights

News

Speaking Engagements

Publications

Honors

Honors

  • The Best Lawyers in America, 2021

Education & Admissions

Education

Northeastern University School of Law, J.D.
Brigham Young University, Sc.B

Admissions

  • Massachusetts

Industry Expertise

Shannon often presents and is quoted in the media on business issues, including transactions, financing, and emerging trends in private equity and venture capital.

Noteworthy

  • The Best Lawyers in America, 2021
Back to Page